Rivaroxaban versus Warfarin for Prevention of Thromboembolism in Bangladeshi Patients with Non-Valvular Atrial Fibrillation. (2020). University Heart Journal, 16(2), 99-105. https://doi.org/10.3329/uhj.v16i2.49666